Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
1.
OTJR (Thorofare N J) ; 44(2): 227-235, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-37248987

RESUMO

Although some people with spinal cord injury (SCI) return to outdoor recreation, many have low activity levels and encounter significant environmental barriers. The purpose of the study was to describe how people with SCI engage in outdoor recreation activities, what meaning they attribute to these, and to inform occupational therapists in promoting outdoor recreation post-SCI. The study used qualitative, descriptive phenomenology. Thirteen participants completed semi-structured interviews, and data were analyzed using thematic analysis. Outdoor recreation contributes to personal well-being. It is a way to share life with loved ones and other disabled people. Having the right equipment and using a trial-and-error approach facilitated participation, which was sometimes supported and frequently constrained by physical, built, and information environments. Findings suggest implications for occupational therapists in the areas of direct intervention, entrepreneurship, and advocacy. These are consistent with the American Occupational Therapy Association Vision 2025 to collaborate for inclusion and accessibility in occupational performance.


Assuntos
Pessoas com Deficiência , Terapia Ocupacional , Traumatismos da Medula Espinal , Humanos , Terapeutas Ocupacionais , Recreação
3.
Nutr Health ; : 2601060231191658, 2023 Jul 27.
Artigo em Inglês | MEDLINE | ID: mdl-37501551

RESUMO

BACKGROUND: Avoidant/restrictive food intake disorder (ARFID) and anorexia nervosa (AN) are characterized by restrictive eating and micronutrient deficiencies. While zinc deficiency has been identified in AN, zinc level in ARFID has not been systematically assessed. AIM: Examine serum zinc levels and their association with eating pathology, psychopathology, and executive functioning in youth with ARFID and AN. METHODS: This study included 28 adolescents (Mage = 13, 75% female) receiving treatment for ARFID (n = 13) and AN (n = 15). Demographic data and intake mood metrics were obtained via chart review. Participants completed the Delis-Kaplan Executive Functioning Systems and their mothers completed the behavior rating inventory of executive function (BRIEF-2). Zinc level was collected via blood draw. Independent samples t-tests, Pearson's chi-square, and Pearson's correlations were used to evaluate between-group differences and the relationship between zinc level and clinical correlates. RESULTS: No between-groups differences emerged in zinc levels, though half the sample demonstrated low levels for their ages. No significant correlations were found between zinc level and demographic data, mood measures, or executive functioning tasks. AN had relatively lower zinc levels, higher eating pathology, and anxiety, though ARFID had a longer duration of illness. Correlations between zinc and BRIEF-2 scores were mixed. CONCLUSION: This is the first study to systematically assess zinc levels in ARFID. While there were no group differences for zinc levels, 50% of the sample had low zinc levels. Zinc level did not correlate with higher psychopathology. Monitoring zinc levels throughout treatment in the context of anabolic processes can inform treatment strategies.

4.
Contemp Clin Trials ; 122: 106937, 2022 11.
Artigo em Inglês | MEDLINE | ID: mdl-36167287

RESUMO

BACKGROUND: This double-blind, placebo-controlled study evaluates the effectiveness of oral naltrexone in adolescents and young adults with eating disorders (EDs) characterized by purging with or without binge-eating behaviors. We hypothesize that participants receiving oral naltrexone will demonstrate greater improvements in body mass index in underweight participants and self-reported ED symptomatology compared to placebo. METHODS: Thirty individuals receiving treatment in a partial hospitalization program for EDs with diagnoses of anorexia nervosa binge-eating/purging type, bulimia nervosa, or purging disorder will receive six weeks of either placebo or oral naltrexone. Participants will complete a battery of self-report measures and laboratory safety monitoring every three weeks in addition to standard of medical care for treatment environment. RESULTS: Analysis will compare outcomes at weeks three and six, and follow-up at nine weeks and six-months across the oral naltrexone and placebo groups. Main effects for time will examine improvements over the course of treatment for all participants, while group × time interactions will examine differences in the rate of change over time between study arms. CONCLUSIONS: We hypothesize that participants receiving oral naltrexone will experience more rapid improvements in symptom severity and weight restoration compared to placebo across study time points. There are very few medications with high-quality data demonstrating both safety and efficacy in the treatment of eating disorders. The authors theorize this study will demonstrate a clinically significant effect of oral naltrexone on impulsive-type EDs and support its use as an effective option for treatment augmentation.


Assuntos
Anorexia Nervosa , Transtorno da Compulsão Alimentar , Bulimia Nervosa , Bulimia , Transtornos da Alimentação e da Ingestão de Alimentos , Adulto Jovem , Adolescente , Humanos , Naltrexona/uso terapêutico , Bulimia Nervosa/tratamento farmacológico , Transtornos da Alimentação e da Ingestão de Alimentos/tratamento farmacológico , Transtorno da Compulsão Alimentar/tratamento farmacológico , Anorexia Nervosa/diagnóstico , Ensaios Clínicos Controlados Aleatórios como Assunto
6.
JMIR Res Protoc ; 9(11): e21015, 2020 Nov 06.
Artigo em Inglês | MEDLINE | ID: mdl-33155572

RESUMO

BACKGROUND: Given that youth alcohol use is more common in rural communities, such communities can play a key role in preventing alcohol use among adolescents. Guidelines recommend primary care providers incorporate screening, brief intervention, and referral to treatment (SBIRT) into routine care. OBJECTIVE: The aim is to train primary care providers and school nurses within a rural 10-county catchment area in Pennsylvania to use SBIRT and facilitate collaboration with community organizations to better coordinate substance use prevention efforts. METHODS: To build capacity to address underage drinking and opioid use among youth aged 9-20 years, this project uses telehealth, specifically Project ECHO (Extension for Community Healthcare Outcomes), to train primary care providers and school nurses to address substance use with SBIRT. Our project will provide 120 primary care providers and allied health professionals as well as 20 school nurses with SBIRT training. Community-based providers will participate in weekly virtual ECHO sessions with a multidisciplinary team from Penn State College of Medicine that will provide SBIRT training and facilitate case discussions among participants. RESULTS: To date, we have launched one SBIRT ECHO project with school personnel, enrolling 34 participants. ECHO participants are from both rural (n=17) and urban (n=17) counties and include school nurses (n=15), school counselors (n=8), teachers (n=5), administrators (n=3), and social workers (n=3). Before the study began, only 2/13 (15.5%) of schools were screening for alcohol use. CONCLUSIONS: This project teaches primary care clinics and schools to use SBIRT to prevent the onset and reduce the progression of substance use disorders, reduce problems associated with substance use disorders, and strengthen communities' prevention capacity. Ours is an innovative model to improve rural adolescent health by reducing alcohol and opioid use. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/21015.

7.
Pediatr Clin North Am ; 66(6): 1135-1147, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-31679603

RESUMO

Cocaine use by adolescents and young adults continues to be a significant public health issue and the cause of medical and psychological morbidity and mortality. Although use rates are lower than those seen with alcohol, tobacco, and other illicit substances such as marijuana, cocaine is highly addictive and presents significant acute and long-term medical and psychological effects. This article reviews the epidemiology of cocaine use among adolescents and young adults, discusses the pharmacology and neurobiology of cocaine use and dependence, provides information regarding acute intoxication and systemic effects seen with more chronic use, and describes current assessment and treatment approaches.


Assuntos
Transtornos Relacionados ao Uso de Cocaína , Adolescente , Comportamento do Adolescente/psicologia , Cocaína/toxicidade , Transtornos Relacionados ao Uso de Cocaína/diagnóstico , Transtornos Relacionados ao Uso de Cocaína/epidemiologia , Transtornos Relacionados ao Uso de Cocaína/terapia , Humanos , Drogas Ilícitas/toxicidade , Estados Unidos/epidemiologia , Adulto Jovem
8.
9.
Pediatrics ; 144(1)2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-31235608

RESUMO

Alcohol use continues to be a major concern from preadolescence through young adulthood in the United States. Results of recent neuroscience research have helped to elucidate neurobiological models of addiction, substantiated the deleterious effects of alcohol on adolescent brain development, and added additional evidence to support the call to prevent and reduce underage drinking. This technical report reviews the relevant literature and supports the accompanying policy statement in this issue of Pediatrics.


Assuntos
Transtornos Relacionados ao Uso de Álcool , Consumo de Álcool por Menores , Adolescente , Desenvolvimento do Adolescente/efeitos dos fármacos , Transtornos Relacionados ao Uso de Álcool/diagnóstico , Transtornos Relacionados ao Uso de Álcool/epidemiologia , Transtornos Relacionados ao Uso de Álcool/psicologia , Transtornos Relacionados ao Uso de Álcool/terapia , Bebidas Alcoólicas/efeitos adversos , Encéfalo/efeitos dos fármacos , Humanos , Fatores de Risco , Consumo de Álcool por Menores/prevenção & controle , Consumo de Álcool por Menores/psicologia , Consumo de Álcool por Menores/estatística & dados numéricos , Estados Unidos/epidemiologia
10.
J Adolesc Health ; 63(3): 327-334, 2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-30097347

RESUMO

PURPOSE: To evaluate a screening, brief intervention and referral to treatment curriculum for alcohol and other substance use developed, implemented and integrated into a pediatric residency program. METHODS: During a 1-month adolescent medicine rotation, pediatric, and medicine/pediatric residents in an urban teaching hospital completed a 2 1/2-hour formal curriculum including a didactic lecture, a 40-minute video describing the Brief Negotiation Interview (BNI), and a skill-based session practicing the BNI and receiving individualized feedback. Access to a website with didactic material was provided. Outcome measures were pre- and post-training knowledge, BNI performance measured with a standardized patient using a validated BNI adherence scale, satisfaction with training, and adoption of BNI into clinical practice. RESULTS: Of the 106 residents trained, 92(87%) completed both pre- and post-test evaluations. Significant improvements were found in pre- versus post-test scores of knowledge, (20.0 [2.4 SD] vs. 24.1 [3.5 SD], p <.001) and BNI performance comparing pre- and post BNI adherence scale total scores, (5.14 [1.8 S.D.] vs. 11.5 [.96], p<.001). Residents reported high satisfaction with training, [1.4, SD .5, immediately and 1.6, SD .6, 30-days post training)with scores ranging from 1 to 5 with lower score=greater satisfaction. During the 12-month follow-up period, we received 83 responses from residents reporting a total of 129 BNIs in actual clinical settings. CONCLUSIONS: A screening, brief intervention and referral to treatment curriculum was successfully integrated into an adolescent medicine elective in a pediatric residency program. Residents demonstrated significant improvements in knowledge and skills performing the BNI, with high satisfaction and adoption of the BNI into clinical practice.


Assuntos
Currículo , Internato e Residência , Programas de Rastreamento , Pediatria/educação , Encaminhamento e Consulta , Transtornos Relacionados ao Uso de Substâncias/terapia , Adolescente , Competência Clínica , Educação de Pós-Graduação em Medicina , Humanos
11.
Pediatrics ; 142(3)2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-30150209

RESUMO

Marijuana is one of the most widely used substances during pregnancy in the United States. Emerging data on the ability of cannabinoids to cross the placenta and affect the development of the fetus raise concerns about both pregnancy outcomes and long-term consequences for the infant or child. Social media is used to tout the use of marijuana for severe nausea associated with pregnancy. Concerns have also been raised about marijuana use by breastfeeding mothers. With this clinical report, we provide data on the current rates of marijuana use among pregnant and lactating women, discuss what is known about the effects of marijuana on fetal development and later neurodevelopmental and behavioral outcomes, and address implications for education and policy.


Assuntos
Canabinoides/efeitos adversos , Uso da Maconha/epidemiologia , Efeitos Tardios da Exposição Pré-Natal/epidemiologia , Aleitamento Materno/efeitos adversos , Canabinoides/farmacocinética , Criança , Feminino , Feto/efeitos dos fármacos , Humanos , Recém-Nascido , Uso da Maconha/efeitos adversos , Gravidez , Complicações na Gravidez/epidemiologia , Resultado da Gravidez/epidemiologia
14.
Pediatrics ; 139(3)2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-28242859

RESUMO

Many states have recently made significant changes to their legislation making recreational and/or medical marijuana use by adults legal. Although these laws, for the most part, have not targeted the adolescent population, they have created an environment in which marijuana increasingly is seen as acceptable, safe, and therapeutic. This clinical report offers guidance to the practicing pediatrician based on existing evidence and expert opinion/consensus of the American Academy of Pediatrics regarding anticipatory guidance and counseling to teenagers and their parents about marijuana and its use. The recently published technical report provides the detailed evidence and references regarding the research on which the information in this clinical report is based.


Assuntos
Aconselhamento , Fumar Maconha/legislação & jurisprudência , Fumar Maconha/prevenção & controle , Pais , Adolescente , Humanos , Abuso de Maconha/prevenção & controle , Pediatras , Papel do Médico
15.
Pediatr Clin North Am ; 64(2): 331-342, 2017 04.
Artigo em Inglês | MEDLINE | ID: mdl-28292449

RESUMO

Menstrual disorders and abnormal uterine bleeding are common concerns of young women. Complaints include menses that are: too painful (dysmenorrhea), absent or occur irregularly (amenorrhea or oligoamenorrhea), or prolonged and heavy (menorrhagia, or excessive uterine bleeding). In providing optimal reproductive care, the medical provider must be able to distinguish between normal developmental patterns or symptoms requiring education and reassurance from pathologic conditions requiring prompt assessment and treatment. This article discusses the normal menstrual patterns seen in adolescent females and provides an evaluation and management approach to primary and secondary dysmenorrhea.


Assuntos
Medicina do Adolescente/métodos , Dismenorreia/diagnóstico , Dismenorreia/tratamento farmacológico , Adolescente , Amenorreia/diagnóstico , Amenorreia/tratamento farmacológico , Anticoncepcionais Orais/uso terapêutico , Feminino , Humanos , Anamnese , Ciclo Menstrual/fisiologia , Saúde Reprodutiva
16.
JAMA Pediatr ; 170(12): 1195-1201, 2016 12 01.
Artigo em Inglês | MEDLINE | ID: mdl-27802492

RESUMO

Importance: National data show a parallel relationship between recent trends in opioid prescribing practices and hospitalizations for opioid poisonings in adults. No similar estimates exist describing hospitalizations for opioid poisonings in children and adolescents. Objective: To describe the incidence and characteristics of hospitalizations attributed to opioid poisonings in children and adolescents. Design, Setting, and Participants: Retrospective analysis of serial cross-sectional data from a nationally representative sample of US pediatric hospital discharge records collected every 3 years from January 1, 1997, through December 31, 2012. The Kids' Inpatient Database was used to identify 13 052 discharge records for patients aged 1 to 19 years who were hospitalized for opioid poisonings. Data were analyzed within the collection time frame. Main Outcomes and Measures: Poisonings attributed to prescription opioids were identified by codes from the International Classification of Diseases, Ninth Revision, Clinical Modification. In adolescents aged 15 to 19 years, poisonings attributed to heroin were also identified. Census estimates were used to calculate incidence per 100 000 population. The Cochran-Armitage test for trend was used to assess for changes in incidence over time. Results: From 1997 to 2012, a total of 13 052 (95% CI, 12 500-13 604) hospitalizations for prescription opioid poisonings were identified. The annual incidence of hospitalizations for opioid poisonings per 100 000 children aged 1 to 19 years rose from 1.40 (95% CI, 1.24-1.56) to 3.71 (95% CI, 3.44-3.98), an increase of 165% (P for trend, <.001). Among children 1 to 4 years of age, the incidence increased from 0.86 (95% CI, 0.60-1.12) to 2.62 (95% CI, 2.17-3.08), an increase of 205% (P for trend, <.001). For adolescents aged 15 to 19 years, the incidence increased from 3.69 (95% CI, 3.20-4.17) to 10.17 (95% CI, 9.48-10.85), an increase of 176% (P for trend, <.001). In this age group, poisonings from heroin increased from 0.96 (95% CI, 0.75-1.18) to 2.51 (95% CI, 2.21-2.80), an increase of 161% (P for trend, <.001); poisonings involving methadone increased from 0.10 (95% CI, 0.03-0.16) to 1.05 (95% CI, 0.87-1.23), an increase of 950% (P for trend, <.001). Conclusions and Relevance: During the course of 16 years, hospitalizations attributed to opioid poisonings rose nearly 2-fold in the pediatric population. Hospitalizations increased across all age groups, yet young children and older adolescents were most vulnerable to the risks of opioid exposure. Mitigating these risks will require comprehensive strategies that target opioid storage, packaging, and misuse.


Assuntos
Analgésicos Opioides/intoxicação , Medicamentos sob Prescrição/intoxicação , Adolescente , Distribuição por Idade , Criança , Pré-Escolar , Estudos Transversais , Overdose de Drogas/epidemiologia , Feminino , Dependência de Heroína/epidemiologia , Hospitalização/tendências , Humanos , Incidência , Lactente , Masculino , Metadona/intoxicação , Estudos Retrospectivos , Comportamento Autodestrutivo/epidemiologia , Suicídio/estatística & dados numéricos , Estados Unidos/epidemiologia , Adulto Jovem
17.
Pediatrics ; 135(3): e769-85, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25624385

RESUMO

This technical report updates the 2004 American Academy of Pediatrics technical report on the legalization of marijuana. Current epidemiology of marijuana use is presented, as are definitions and biology of marijuana compounds, side effects of marijuana use, and effects of use on adolescent brain development. Issues concerning medical marijuana specifically are also addressed. Concerning legalization of marijuana, 4 different approaches in the United States are discussed: legalization of marijuana solely for medical purposes, decriminalization of recreational use of marijuana, legalization of recreational use of marijuana, and criminal prosecution of recreational (and medical) use of marijuana. These approaches are compared, and the latest available data are presented to aid in forming public policy. The effects on youth of criminal penalties for marijuana use and possession are also addressed, as are the effects or potential effects of the other 3 policy approaches on adolescent marijuana use. Recommendations are included in the accompanying policy statement.


Assuntos
Pesquisa Biomédica/legislação & jurisprudência , Canabinoides/farmacologia , Cannabis , Fumar Maconha/legislação & jurisprudência , Pediatria/legislação & jurisprudência , Política Pública , Adolescente , Humanos , Estados Unidos
18.
Sex Health ; 11(3): 274-9, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24990400

RESUMO

UNLABELLED: Background Human papillomavirus (HPV) is the most common sexually transmissible infection (STI) in the United States (US) and an important cause of several cancers. Vaccines that prevent HPV infections are now recommended for routine use in adolescents but coverage remains suboptimal in the US. Because they are often promoted as cancer prevention vaccines, little is known about parents' views on vaccination for prevention of an STI. METHODS: In this qualitative study, parents and caregivers of children ages 10-18 years completed an in-depth interview. Participants (n=38) were recruited from an urban hospital-based primary care centre serving a low-income population in the north-eastern US during May 2013-February 2014. Interviews were transcribed and coded using a thematic content approach. RESULTS: Five major themes emerged with relevance to the topic of HPV vaccination for STI prevention: (1) low awareness of HPV as an STI; (2) favourable opinions about STI prevention messages for vaccination, including at young ages; (3) salience of sexual mode of transmission, given the unpredictability of adolescent sexual behaviour and high rates of other STIs and teen pregnancy; (4) recognition that sexual health is a topic of conversation between adolescents and health care providers; and(5) relevance of personal experience. CONCLUSIONS: Discussing STI prevention in the context of HPV vaccination appears to be well accepted by urban, low-income minority families. In addition to providing information on cancer prevention, these messages may help to raise awareness, acceptability and uptake of HPV vaccines.

20.
Pediatrics ; 133(6): e1798-1807, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24864184

RESUMO

Drug testing is often used as part of an assessment for substance use in children and adolescents. However, the indications for drug testing and guidance on how to use this procedure effectively are not clear. The complexity and invasiveness of the procedure and limitations to the information derived from drug testing all affect its utility. The objective of this clinical report is to provide guidance to pediatricians and other clinicians on the efficacy and efficient use of drug testing on the basis of a review of the nascent scientific literature, policy guidelines, and published clinical recommendations.


Assuntos
Alcoolismo/diagnóstico , Avaliação Pré-Clínica de Medicamentos/métodos , Drogas Ilícitas/análise , Transtornos Relacionados ao Uso de Substâncias/diagnóstico , Adolescente , Alcoolismo/reabilitação , Criança , Serviço Hospitalar de Emergência , Etanol/efeitos adversos , Etanol/farmacocinética , Humanos , Drogas Ilícitas/efeitos adversos , Drogas Ilícitas/farmacocinética , Recém-Nascido , Abuso de Maconha/diagnóstico , Abuso de Maconha/reabilitação , Taxa de Depuração Metabólica/fisiologia , Valor Preditivo dos Testes , Manejo de Espécimes , Transtornos Relacionados ao Uso de Substâncias/reabilitação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA